CD40-activated B cells induce anti-tumor immunity in vivo-Reference-Cited by-同舟云学术

CD40-activated B cells induce anti-tumor immunity in vivo

Published:2016-02-25 Issue:17 Volume:8 Page:27740-27753
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wennhold Kerstin¹,Weber Tanja M.¹,Klein-Gonzalez Nela²,Thelen Martin¹,Garcia-Marquez Maria¹,Chakupurakal Geothy¹,Fiedler Anne¹,Schlösser Hans A.¹³,Fischer Rieke⁴,Theurich Sebastian¹⁵,Shimabukuro-Vornhagen Alexander¹,von Bergwelt-Baildon Michael¹

Affiliation:

1. Cologne Interventional Immunology (CII), Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

2. Department of Hematology, Vall d’Hebron University Hospital, Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain

3. Department of General, Visceral and Cancer Surgery, University Hospital of Cologne, Cologne, Germany

4. Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

5. Laboratory for Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research Cologne, Cologne, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis;Aging;2024-01-12

2. MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4 ⁺ T cells in vivo;OncoImmunology;2023-12-10

3. Lymph-Node-Based CD3 ⁺ CD20 ⁺ Cells Emerge from Membrane Exchange between T Follicular Helper Cells and B Cells and Increase Their Frequency following Simian Immunodeficiency Virus Infection;Journal of Virology;2023-06-29

4. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors;Frontiers in Immunology;2023-06-26

5. Exploring the reprogramming potential of B cells and comprehending its clinical and therapeutic perspective;Transplant Immunology;2023-06